ProShare Advisors
NMTR

ProShare Advisors’s 9 Meters Biopharma NMTR Stock Holding History

ProShare Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,123
Closed -$26K – 2227
2022
Q1 		$26K Sell
2,123
-350
-14% -$4.78K ﹤0.01% 2164
2021
Q4 		$48K Buy
2,473
+1,042
+73% +$23.3K ﹤0.01% 2293
2021
Q3 		$37K Sell
1,431
-1,326
-48% -$31.2K ﹤0.01% 1982
2021
Q2 		$61K Buy
+2,757
New +$67.7K ﹤0.01% 2346

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Curi Wealth Management Raleigh, North Carolina $724M AUM 17.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

ProShare Advisors's NMTR Position: Q2 2022 in Review

ProShare Advisors sold out of 9 Meters Biopharma (NMTR) in Q2 2022, closing a stake of 2,123 shares — an estimated $26K sold.

ProShare Advisors first reported a position in NMTR in Q2 2021 and held it in 4 quarters. The position peaked at $61K in Q2 2021. 88 funds tracked by Wall St. Rank hold NMTR as of Q2 2022.

  • ProShare Advisors reported no remaining 9 Meters Biopharma position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 2,123 9 Meters Biopharma shares in Q2 2022, an estimated $26K.
  • ProShare Advisors first reported a position in 9 Meters Biopharma in Q2 2021 and held it in 4 quarters.
  • ProShare Advisors's 9 Meters Biopharma position peaked at $61K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.